TG Therapeutics, Inc. 13F holders
Of the 44 funds followed here, 8 reported a position in TG Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 3.6 million shares worth $200.1 million, 0.0% of its reported book. New this quarter: Point72 Asset Management.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 3,642,216 | $200.1 million | 0.0% | +142,300 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 2,506,871 | $137.7 million | 0.1% | +964,559 | added | 30 June 2026 | 13F |
| Citadel Advisors | 1,240,670 | $68.2 million | 0.0% | -1,203,219 | trimmed | 30 June 2026 | 13F |
| FMR LLC | 1,018,814 | $56.0 million | 0.0% | +738,368 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 679,300 | $37.3 million | 0.1% | +338,400 | added | 30 June 2026 | 13F |
| Bridgewater Associates | 429,904 | $23.6 million | 0.1% | +118,489 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 367,163 | $20.2 million | 0.0% | +367,163 | new | 30 June 2026 | 13F |
| Millennium Management | 281,611 | $15.5 million | 0.0% | +120,724 | added | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 29 April 2026 | 13G | Vanguard Portfolio Management and 1 other | 8.4 million | 5.3% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 10 November 2025 | 13G | State Street Corporation and 1 other | 8.1 million | 5.1% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 8 September 2026 | 12,589 | $55.99 | SEC |
| 3 September 2026 | 499 | $56.90 | SEC |
| 24 August 2026 | 11 | $54.27 | SEC |
| 13 August 2026 | 3,685 | $49.50 | SEC |
| 12 August 2026 | 4 | $49.90 | SEC |
| 7 August 2026 | 2,340 | $49.55 | SEC |
| 6 August 2026 | 84 | $49.88 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 12,589 on 8 September 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to TGTX by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.